Investigates changes in alcohol use and liver fibrosis during the COVID-19 pandemic, highlighting public health concerns.
Aims We aim to investigate alcohol consumption patterns before and after the pandemic onset and utilize liver fibrosis measurements to identify at-risk drinking patterns. Methods We selected 10 259 participants in the National Health and Nutrition Examination Survey across two cohorts: January 2017–March 2020 (pre-pandemic) and August 2021–August 2023 (during-pandemic). We employed the alcohol use questionnaire to identify drinking patterns, including heavy drinking and binge drinking frequencies. Vibration-controlled transient elastography was used to define stage 1 and significant liver fibrosis by liver stiffness measurement >7 to 9 and > 9 kPa, respectively. We first compared the prevalence and frequencies of binge drinking and single day heavy drinking between the two cohorts. We then calculated the odds of liver fibrosis among during-pandemic participants with various alcohol use patterns, compared to pre-pandemic participants with the same use patterns. Results We found a higher prevalence of at-risk alcohol use in the during-pandemic cohort, including single-day heavy drinking and binge drinking at least once a month. Notably, the distributions of the frequency of single day heavy drinking and binge drinking were skewed towards a higher frequency of at-risk alcohol use in the during-pandemic group. Furthermore, the odds of significant liver fibrosis were higher among during-pandemic non-heavy/binge drinkers and heavy/binge drinkers, compared to their pre-pandemic counterparts. Conclusions The data showed increases in heavy drinking and binge drinking in the during-pandemic cohort, which calls for urgent public health interventions to mitigate future adverse health impacts.
No takes yet. Share an insight, caveat, or question.
Ting et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: